Losartan 50mg + Amlodipine 5mg Tablet in pharma franchise in Kolkata

Losartan 50mg + Amlodipine 5mg Tablet in PCD pharma franchise in Surat

Losartan 50mg + Amlodipine 5mg Tablet in top pharma company in Pune

Losartan 50mg + Amlodipine 5mg Tablet in PCD pharma supplier in Jaipur

Losartan 50mg + Amlodipine 5mg Tablet in pharma franchise company in India
Losartan 50mg + Amlodipine 5mg Tablet in pharma distributor in Chandigarh

Home/Products /losartan-50-mg-amlodipine-5-mg-tablet

Lorsan AM Tablet

Composition : Losartan 50mg + Amlodipine 5mg Tablet

Dosage Form : Tablet

Packaging Type : Alu Alu

Packaging : 10*15

Price : ₹144/-

Lorsan AM is a dual-action tablet specifically formulated to manage hypertension and improve cardiovascular health. This innovative combination includes two active ingredients: Losartan (50 mg) and Amlodipine (5 mg). Together, these medications work synergistically to effectively lower blood pressure and reduce the risk of cardiovascular complications.

Losartan is an angiotensin II receptor blocker (ARB) that helps relax blood vessels by inhibiting the action of angiotensin II, a hormone that causes blood vessels to constrict. By blocking this hormone, Losartan effectively lowers blood pressure and improves blood flow, which is essential for reducing the workload on the heart. Amlodipine, a calcium channel blocker, complements this action by preventing calcium from entering the smooth muscle cells of the heart and blood vessels. This results in further relaxation of the blood vessels, leading to decreased blood pressure and improved oxygen delivery to the heart.

The combination of Losartan and Amlodipine in Lorsan AM not only helps in achieving better blood pressure control but also provides additional benefits, such as reducing the risk of heart attacks and strokes. This makes it an essential option for patients with hypertension, particularly those who may require multiple mechanisms of action to manage their condition effectively.

Read More

About the Product

Lorsan AM is a dual-action tablet specifically formulated to manage hypertension and improve cardiovascular health. This innovative combination includes two active ingredients: Losartan (50 mg) and Amlodipine (5 mg). Together, these medications work synergistically to effectively lower blood pressure and reduce the risk of cardiovascular complications.

Losartan is an angiotensin II receptor blocker (ARB) that helps relax blood vessels by inhibiting the action of angiotensin II, a hormone that causes blood vessels to constrict. By blocking this hormone, Losartan effectively lowers blood pressure and improves blood flow, which is essential for reducing the workload on the heart. Amlodipine, a calcium channel blocker, complements this action by preventing calcium from entering the smooth muscle cells of the heart and blood vessels. This results in further relaxation of the blood vessels, leading to decreased blood pressure and improved oxygen delivery to the heart.

The combination of Losartan and Amlodipine in Lorsan AM not only helps in achieving better blood pressure control but also provides additional benefits, such as reducing the risk of heart attacks and strokes. This makes it an essential option for patients with hypertension, particularly those who may require multiple mechanisms of action to manage their condition effectively.

Common side effects may include dizziness, swelling of the ankles or feet, flushing, and fatigue. Patients should be monitored for any signs of allergic reactions or unusual symptoms.

Lorsan AM is indicated for the treatment of hypertension and the reduction of cardiovascular risk in patients with high blood pressure.

Consult your healthcare provider before starting this medication, especially if you have a history of kidney or liver disease.

Store Lorsan AM tablets in a cool, dry place, away from direct sunlight and moisture. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation